Blood Pressure-Lowering Effects of Aldosterone Synthase Inhibitors-A Systematic Review.
Explores aldosterone synthase inhibitors as a novel therapeutic pathway for managing resistant hypertension and cardiorenal risk in CKD patients.
More from ASNRT News
Browse the latest news, society announcements, KDIGO guideline updates, and AJNT issue releases on the ASNRT newsroom.
All news · ASNRT home